biomarin pharmaceutical inc
(BMRN:NASDAQ GS)

Executive Profile*

Background*

Mr. Stephen L. Hauser, M.D serves as a Professor and Chair of Department of Neurology, University of California, San Francisco. Mr. Hauser is a neuroimmunologist, Dr. Hauser's research has advanced understanding of the genetic basis, immune mechanisms, and treatment of multiple sclerosis. He served as President of the American Neurological Association and President of the Medical Staff at UCSF. Dr. Hauser serves as Chairman of Scientific Advisory Board at Buck Institute ... For Age Research and serves as its Trustee. Dr. Hauser serves as Member of Scientific Advisory Board of Rinat Neuroscience Corporation. Dr. Hauser serves as Member of Clinical Advisory Board at Receptos, Inc. He serves as Member of Scientific Advisory Board at BioMarin Pharmaceutical Inc. He was a faculty member at Harvard Medical School before moving to UCSF. Dr. Hauser has received numerous awards and honors for his work, including the Jacob Javits Neuroscience Investigator Award and the John Dystel Prize for Multiple Sclerosis Research. Dr. Hauser is a fellow of the American Academy of Arts and Sciences and the American Academy of Physicians, a member of the Institute of Medicine of the National Academy of Sciences (currently Chair of the Committee on Gulf War and Health Outcomes), an editor of the textbook Harrison's Principles of Internal Medicine, and editor-in-chief of Annals of Neurology. He trained in internal medicine at the New York Hospital-Cornell Medical Center, in neurology at the Massachusetts General Hospital (MGH), and in immunology at Harvard Medical School and the Institute Pasteur in Paris, France. Dr. Hauser is a graduate of MIT (Phi Beta Kappa) and Harvard Medical School (Magna Cum Laude).

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BMRN:US	$65.00 USD	+2.57

COMPETITOR COMPENSATION